H

Hospital Felicio Rocho | Health Sciences Center

Research site
(Unclaimed)
Location
Rua Uberaba 500, Belo Horizonte, Minas Gerais, Brazil

Site insights

Top conditions

Top treatments

Etrolizumab
Isavuconazole
Leronlimab
Aldosterone
Plitidepsin
Bevacizumab
Oxaliplatin
Mirikizumab
EMPagliflozin
Atezolizumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 24 total trials

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

This is a Phase III, open-label, multicenter, randomized, two-arm study designed to evaluate the efficacy and safety of atezolizumab plus either lenv...

Active, not recruiting
Unresectable Hepatocellular Carcinoma
Drug: Lenvatinib
Drug: Atezolizumab

This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeu...

Enrolling
Community-acquired Pneumonia
Drug: Heparin

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Enrolling
Chronic Kidney Disease
Inflammation
Drug: Placebo (Ziltivekimab B)
Drug: Placebo (Ziltivekimab C)

Trial sponsors

Roche logo
Astellas logo
Boehringer Ingelheim logo
AstraZeneca logo
E
Fresenius Kabi logo
Lilly logo
Novo Nordisk logo
Pfizer logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems